ZOPAPOGENE IMADENOVEC
Brand names: PAPZIMEOS
Mechanism of Action
12.1 Mechanism of Action PAPZIMEOS is a non-replicating adenoviral vector-based immunotherapy designed to express a fusion antigen of selected regions of human papillomavirus (HPV) proteins expressed in HPV 6- and HPV 11-infected cells. PAPZIMEOS is designed to generate an immune response directed against HPV 6 and HPV 11 proteins in patients with recurrent respiratory papillomatosis.
Indications
Contraindications
- • 4 CONTRAINDICATIONS None. None. ( 4 )
FDA Warnings
- 5 WARNINGS AND PRECAUTIONS Injection-site reactions: Injection-site reactions, have been observed
Known Side Effects
0 documented side effects by frequency
No structured side effect data available.
Community Discussions
No community discussions found for ZOPAPOGENE IMADENOVEC yet.
Compare With
0 available comparisons
No comparisons yet.
Formulations
Dosage Forms
Tablet
Route
Subcutaneous